Drugs / Perflubutane Microbubble
Perflubutane Microbubble
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05105087 | Apr 2022 → Nov 2023 | cervical carcinoma, vaginal carcinoma, vulvar carcinoma | Thomas Jefferson University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Perflubutane Microbubble | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05105087 ↗ |
| Modality | Diagnostic / imaging agent | “The ultrasound contrast agent is called Sonazoid” NCT05105087 ↗ |
| Route | Subcutaneous | “Given subdermally” NCT05105087 ↗ |